论文部分内容阅读
目的:研究并分析治疗慢性心力衰竭患者时使用卡维地洛的治疗效果。方法:收集慢性心力衰竭患者共85例,根据患者入院日期的单双号数分为42例对照组和43例观察组,对照组患者接受常规治疗,观察组在此基础上联合使用卡维地洛,将两组患者的心脏射血分数及心率变异性指标进行观察和对比。结果:观察组患者的心脏射血分数显著高于对照组患者,观察组患者的心率变异性指标均显著优于对照组(P均<0.05)。结论:在慢性心力衰竭患者的治疗过程中,卡维地洛能够有效提高患者的心脏功能,增强收缩力并提高心脏的排血量,有助于提升患者的生活质量,值得推广应用。
Objective: To study and analyze the therapeutic effect of carvedilol in the treatment of patients with chronic heart failure. Methods: A total of 85 patients with chronic heart failure were collected. According to the single and double numbers of patients admitted to hospital, 42 patients in control group and 43 patients in observation group were enrolled. Patients in control group received conventional therapy. On the basis of this, Luo, the two groups of patients with cardiac ejection fraction and heart rate variability were observed and compared. Results: The heart ejection fraction of the observation group was significantly higher than that of the control group. The heart rate variability index of the observation group was significantly better than that of the control group (all P <0.05). Conclusion: In the treatment of patients with chronic heart failure, carvedilol can effectively improve the patient’s cardiac function, enhance the contractility and increase the cardiac output, help to improve the quality of life of patients, it is worth promoting the application.